iRhythm Holdings, Inc. (IRTC) shareholders
Close on Nov 17, 2026Market cap $2.96BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 2,494,403 | 8.10% | 13G (passive) amendment | Dec 31, 2023 |
| Roderick Wong Joint filing with RTW Investments, LP (6.60%) | 2,182,631 | 6.60% | 13G (passive) amendment | Jun 30, 2026 |
| Vanguard Portfolio Management | 1,824,090 | 5.64% | 13G (passive) | Mar 31, 2026 |
| Vanguard Capital Management | 1,691,483 | 5.23% | 13G (passive) | Mar 31, 2026 |
| Artisan Partners Holdings LP Joint filing with Artisan Partners Asset Management Inc. (5.10%), Artisan Investments GP LLC (5.10%) and 1 more | 1,660,307 | 5.10% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IRTC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,985,667 | 9.06% | $355.15M | +244,162 | 0.01% |
| Rtw Investments, LP | 2,182,631 | 6.62% | $259.62M | +514,131 | 2.22% |
| Vanguard Portfolio Management LLC | 1,913,976 | 5.81% | $227.67M | +117,604 | 0.01% |
| Artisan Partners Limited Partnership | 1,660,307 | 5.04% | $197.49M | +209,400 | 0.31% |
| Vanguard Capital Management LLC | 1,463,211 | 4.44% | $174.05M | +17,501 | 0.00% |
| Millennium Management LLC | 1,406,454 | 4.27% | $167.30M | −201,560 | 0.06% |
| FMR LLC | 1,191,982 | 3.62% | $141.79M | −169,937 | 0.01% |
| UBS Asset Management Americas Inc | 944,517 | 2.87% | $112.35M | −102,935 | 0.02% |
| Geode Capital Management, LLC | 881,899 | 2.68% | $104.92M | +64,789 | 0.01% |
| Eventide Asset Management, LLC | 880,338 | 2.67% | $104.71M | +119,513 | 1.40% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 866,528 | 2.63% | $103.07M | +104,466 | 0.10% |
| State Street Corp | 856,517 | 2.60% | $101.88M | +68,215 | 0.00% |
| Holocene Advisors, LP | 783,636 | 2.38% | $93.21M | −465,022 | 0.21% |
| JPMorgan Chase & Co | 766,216 | 2.32% | $90.92M | +51,320 | 0.01% |
| Stephens Investment Management Group LLC | 693,437 | 2.10% | $82.48M | +131,907 | 0.88% |
| Fuller & Thaler Asset Management, Inc. | 685,496 | 2.08% | $81.54M | +10,798 | 0.22% |
| Braidwell LP | 654,262 | 1.98% | $77.82M | +44,070 | 2.88% |
| D. E. Shaw & Co., Inc. | 629,686 | 1.91% | $74.90M | +75,420 | 0.04% |
| Manufacturers Life Insurance Company, The | 561,251 | 1.70% | $66.76M | +170,674 | 0.05% |
| Blair William & Co/Il | 524,690 | 1.59% | $62.41M | −103,695 | 0.16% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 304 | 36M | 100.0% | 45 / 120 | 91 / 40 | 4M | 4M |
| Q1 2026 | 305 | 36M | 100.0% | 44 / 112 | 106 / 69 | 10M | 7M |
| Q4 2025 | 335 | 36M | 100.0% | 46 / 109 | 122 / 41 | 5M | 4M |
| Q3 2025 | 337 | 35M | 100.0% | 63 / 110 | 114 / 28 | 4M | 4M |
| Q2 2025 | 303 | 35M | 100.0% | 71 / 100 | 94 / 22 | 4M | 5M |
| Q1 2025 | 256 | 36M | 100.0% | 54 / 81 | 82 / 22 | 5M | 6M |
| Q4 2024 | 227 | 37M | 100.0% | 41 / 72 | 82 / 52 | 8M | 6M |
| Q3 2024 | 242 | 35M | 100.0% | 49 / 87 | 70 / 32 | 6M | 4M |
| Q2 2024 | 228 | 37M | 100.0% | 27 / 106 | 66 / 51 | 4M | 3M |
| Q1 2024 | 253 | 36M | 100.0% | 52 / 77 | 90 / 21 | 5M | 3M |
| Q4 2023 | 222 | 35M | 100.0% | 34 / 89 | 68 / 33 | 5M | 4M |
| Q3 2023 | 223 | 33M | 100.0% | 38 / 76 | 77 / 16 | 3M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
290 funds held IRTC in Q2 2026, 36% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of IRTC | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,026,322 | 3.11% | $122.08M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 860,238 | 2.61% | $102.33M | 0.12% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 741,498 | 2.25% | $88.20M | 0.05% | Jun 30, 2026 |
| Eventide Gilead Fund | 582,472 | 1.77% | $69.29M | 2.01% | Jun 30, 2026 |
| Vanguard Explorer Fund | 521,698 | 1.58% | $61.13M | 0.28% | Jul 31, 2026 |
| Select Medical Technology and Devices Portfolio | 450,000 | 1.37% | $51.26M | 1.72% | May 31, 2026 |
| Fullerthaler Behavioral Small-Cap Growth | 447,100 | 1.36% | $53.18M | 0.86% | Jun 30, 2026 |
| Bridge Builder Small/Mid Cap Growth Fund | 435,607 | 1.32% | $51.82M | 0.46% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 427,292 | 1.30% | $50.83M | 0.11% | Jun 30, 2026 |
| Artisan Mid Cap Fund | 378,618 | 1.15% | $45.04M | 1.41% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 377,971 | 1.15% | $44.96M | 0.05% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 361,729 | 1.10% | $42.38M | 0.12% | Jul 31, 2026 |
| SMALLCAP World Fund Inc | 326,172 | 0.99% | $38.80M | 0.04% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 305,804 | 0.93% | $36.38M | 0.24% | Jun 30, 2026 |
| Eventide Healthcare & Life Sciences Fund | 277,739 | 0.84% | $33.04M | 1.85% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Quentin S. Blackford | President and CEO, Director | 226,008 | 0.69% | Aug 11, 2026 |
| Daniel G. Wilson | Chief Financial Officer | 34,987 | 0.11% | Sep 3, 2026 |
| Sumi Shrishrimal | EVP, Chief Risk Officer | 44,621 | 0.14% | Aug 11, 2026 |
| Minang Turakhia | CHIEF MED/SCI OFCR EVP ADVTECH | 60,116 | 0.18% | Aug 11, 2026 |
| Chad Patterson | CHIEF COMM & PRODUCT OFFICER | 62,125 | 0.19% | Aug 11, 2026 |
| Patrick Michael Murphy | CBO and CLO | 69,699 | 0.21% | Aug 11, 2026 |
| Mervin Smith | EVP Strategic Business Ops | 22,410 | 0.07% | Aug 4, 2026 |
| Julianne Rodda | EVP, CHIEF PEOPLE OFFICER | 18,201 | 0.06% | Aug 4, 2026 |
| Sean Clinton Freeman | EVP, Strategy & Corp Devt | 13,641 | 0.04% | Jul 6, 2026 |
| Marc Wade Rosenbaum | Chief Accounting Officer | 16,155 | 0.05% | Jun 3, 2026 |
| Brian Lee Lawrence | Chief Technology Officer | 20,154 | 0.06% | May 5, 2026 |
| Karen K. McGinnis | Director | 3,608 | 0.01% | May 29, 2026 |
| Abhijit Y. Talwalkar | Director | 21,872 | 0.07% | May 29, 2026 |
| Brian B. Yoor | Director | 7,171 | 0.02% | May 29, 2026 |
| Bruce G. Bodaken | Director | 14,211 | 0.04% | May 29, 2026 |
| Merz Cathleen Noel Bairey | Director | 10,546 | 0.03% | May 29, 2026 |
| Karen Ling | Director | 11,141 | 0.03% | May 29, 2026 |
| Kevin C. Oboyle | Director | 3,608 | 0.01% | May 29, 2026 |
| Jason H. Patten | Director | 4,436 | 0.01% | Mar 19, 2026 |
| Ralph Snyderman | Director | 13,288 | 0.04% | May 29, 2025 |
| Mark J. Rubash | Director | 13,788 | 0.04% | May 29, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Daniel G. Wilson Chief Financial Officer | Sep 2, 2026 | Sale | −773 | $121.83 | $94.17K | 34,887 |
| Chad Patterson CHIEF COMM & PRODUCT OFFICER | Aug 10, 2026 | Sale | −7,093 | $124.65 | $884.14K | 62,125 |
| Minang Turakhia CHIEF MED/SCI OFCR EVP ADVTECH | Aug 10, 2026 | Sale | −7,093 | $124.65 | $884.14K | 60,116 |
| Sumi Shrishrimal EVP, Chief Risk Officer | Aug 10, 2026 | Sale | −5,372 | $124.65 | $669.62K | 44,621 |
| Quentin S. Blackford President and CEO, Director | Aug 10, 2026 | Sale | −26,859 | $124.65 | $3.35M | 226,008 |
| Patrick Michael Murphy CBO and CLO | Aug 10, 2026 | Sale | −7,093 | $124.65 | $884.14K | 69,699 |
| Chad Patterson CHIEF COMM & PRODUCT OFFICER | Aug 7, 2026 | Award | +13,589 | – | – | 69,218 |
| Minang Turakhia CHIEF MED/SCI OFCR EVP ADVTECH | Aug 7, 2026 | Award | +13,589 | – | – | 67,209 |
| Sumi Shrishrimal EVP, Chief Risk Officer | Aug 7, 2026 | Award | +9,706 | – | – | 49,993 |
| Quentin S. Blackford President and CEO, Director | Aug 7, 2026 | Award | +48,534 | – | – | 252,867 |
| Patrick Michael Murphy CBO and CLO | Aug 7, 2026 | Award | +13,589 | – | – | 76,792 |
| Julianne Rodda EVP, CHIEF PEOPLE OFFICER | Aug 3, 2026 | Sale | −2,112 | $122.12 | $257.92K | 18,201 |
| Chad Patterson CHIEF COMM & PRODUCT OFFICER | Aug 3, 2026 | Sale | −2,712 | $122.12 | $331.19K | 55,629 |
| Mervin Smith EVP Strategic Business Ops | Aug 3, 2026 | Sale | −617 | $122.12 | $75.35K | 22,410 |
| Minang Turakhia CHIEF MED/SCI OFCR EVP ADVTECH | Jul 2, 2026 | Sale | −1,423 | $124.71 | $177.46K | 53,620 |
| Sean Clinton Freeman EVP, Strategy & Corp Devt | Jul 2, 2026 | Sale | −918 | $124.71 | $114.48K | 13,641 |
| Sumi Shrishrimal EVP, Chief Risk Officer | Jun 2, 2026 | Sale | −1,716 | $108.19 | $185.65K | 40,287 |
| Marc Wade Rosenbaum Chief Accounting Officer | Jun 2, 2026 | Sale | −729 | $108.19 | $78.87K | 16,155 |
| Sumi Shrishrimal EVP, Chief Risk Officer | May 29, 2026 | Award | +133 | $96.82 | $12.88K | 42,003 |
| Marc Wade Rosenbaum Chief Accounting Officer | May 29, 2026 | Award | +178 | $96.82 | $17.23K | 16,884 |
| Sean Clinton Freeman EVP, Strategy & Corp Devt | May 29, 2026 | Award | +273 | $96.82 | $26.43K | 14,559 |
| Chad Patterson CHIEF COMM & PRODUCT OFFICER | May 29, 2026 | Award | +177 | $96.82 | $17.14K | 58,341 |
| Quentin S. Blackford President and CEO, Director | May 29, 2026 | Award | +178 | $96.82 | $17.23K | 204,333 |
| Minang Turakhia CHIEF MED/SCI OFCR EVP ADVTECH | May 29, 2026 | Award | +137 | $96.82 | $13.26K | 55,043 |
| Karen K. McGinnis Director | May 27, 2026 | Award | +1,573 | – | – | 3,608 |
| Merz Cathleen Noel Bairey Director | May 27, 2026 | Award | +1,573 | – | – | 10,546 |
| Bruce G. Bodaken Director | May 27, 2026 | Award | +1,573 | – | – | 14,211 |
| Brian B. Yoor Director | May 27, 2026 | Award | +1,573 | – | – | 7,171 |
| Abhijit Y. Talwalkar Director | May 27, 2026 | Award | +1,573 | – | – | 21,872 |
| Karen Ling Director | May 27, 2026 | Award | +1,573 | – | – | 11,141 |
| Kevin C. Oboyle Director | May 27, 2026 | Award | +1,573 | – | – | 3,608 |
| Abhijit Y. Talwalkar Director | May 11, 2026 | Sale(10b5-1 plan) | −2,293 | $118.02 | $270.62K | 21,736 |
| Abhijit Y. Talwalkar Director | May 11, 2026 | Buy | +5,312 | $10.71 | $56.89K | 25,611 |
| Abhijit Y. Talwalkar Director | May 11, 2026 | Sale(10b5-1 plan) | −940 | $116.05 | $109.09K | 24,671 |
| Abhijit Y. Talwalkar Director | May 11, 2026 | Sale(10b5-1 plan) | −290 | $120.53 | $34.95K | 20,299 |
| Abhijit Y. Talwalkar Director | May 11, 2026 | Sale(10b5-1 plan) | −1,147 | $119.16 | $136.68K | 20,589 |
| Abhijit Y. Talwalkar Director | May 11, 2026 | Sale(10b5-1 plan) | −642 | $116.98 | $75.10K | 24,029 |
| Brian Lee Lawrence Chief Technology Officer | May 4, 2026 | Sale | −1,014 | $120.80 | $122.49K | 20,154 |
| Mervin Smith EVP Strategic Business Ops | Mar 16, 2026 | Sale(10b5-1 plan) | −2,585 | $114.30 | $295.47K | 23,027 |
| Jason H. Patten Director | Mar 12, 2026 | Award | +2,218 | – | – | 4,436 |
| Quentin S. Blackford President and CEO, Director | Mar 2, 2026 | Sale | −4,347 | $128.44 | $558.33K | 213,621 |
| Quentin S. Blackford President and CEO, Director | Mar 2, 2026 | Sale | −5,423 | $128.44 | $696.53K | 204,155 |
| Quentin S. Blackford President and CEO, Director | Mar 2, 2026 | Sale | −4,043 | $128.44 | $519.28K | 209,578 |
| Sumi Shrishrimal EVP, Chief Risk Officer | Mar 2, 2026 | Sale | −978 | $128.44 | $125.61K | 41,870 |
| Sumi Shrishrimal EVP, Chief Risk Officer | Mar 2, 2026 | Sale | −946 | $128.44 | $121.50K | 43,754 |
| Sumi Shrishrimal EVP, Chief Risk Officer | Mar 2, 2026 | Sale | −906 | $128.44 | $116.37K | 42,848 |
| Daniel G. Wilson Chief Financial Officer | Mar 2, 2026 | Sale | −755 | $128.44 | $96.97K | 38,300 |
| Daniel G. Wilson Chief Financial Officer | Mar 2, 2026 | Sale | −815 | $128.44 | $104.68K | 37,485 |
| Daniel G. Wilson Chief Financial Officer | Mar 2, 2026 | Sale | −564 | $128.45 | $72.45K | 36,921 |
| Daniel G. Wilson Chief Financial Officer | Mar 2, 2026 | Sale | −1,261 | $128.45 | $161.98K | 35,660 |
| Minang Turakhia CHIEF MED/SCI OFCR EVP ADVTECH | Mar 2, 2026 | Sale | −1,310 | $128.45 | $168.27K | 56,136 |
| Minang Turakhia CHIEF MED/SCI OFCR EVP ADVTECH | Mar 2, 2026 | Sale | −1,230 | $128.45 | $157.99K | 54,906 |
| Minang Turakhia CHIEF MED/SCI OFCR EVP ADVTECH | Mar 2, 2026 | Sale | −1,487 | $128.45 | $191.01K | 57,446 |
| Marc Wade Rosenbaum Chief Accounting Officer | Mar 2, 2026 | Sale | −417 | $128.45 | $53.56K | 16,706 |
| Marc Wade Rosenbaum Chief Accounting Officer | Mar 2, 2026 | Sale | −399 | $128.45 | $51.25K | 17,123 |
| Patrick Michael Murphy CBO and CLO | Mar 2, 2026 | Sale | −1,139 | $128.45 | $146.30K | 63,203 |
| Patrick Michael Murphy CBO and CLO | Mar 2, 2026 | Sale | −2,028 | $128.44 | $260.48K | 65,532 |
| Patrick Michael Murphy CBO and CLO | Mar 2, 2026 | Sale | −1,190 | $128.44 | $152.84K | 64,342 |
| Chad Patterson CHIEF COMM & PRODUCT OFFICER | Mar 2, 2026 | Sale | −3,030 | $128.44 | $389.17K | 58,164 |
| Chad Patterson CHIEF COMM & PRODUCT OFFICER | Mar 2, 2026 | Sale | −1,414 | $128.44 | $181.61K | 61,194 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of iRhythm's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,114 shares on Aug 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Abhijit Y. Talwalkar Director | May 11, 2026 | 5,312 | $626.43K | May 11, 2026 | Stock Option Exercise |
| Mervin Smith Officer | Mar 16, 2026 | 2,585 | $295.47K | Mar 16, 2026 | Performance Shares |
| Mervin Smith Officer | Feb 24, 2026 | 732 | $103.15K | Feb 24, 2026 | Restricted Stock |
| Marc Wade Rosenbaum Officer | Feb 24, 2026 | 280 | $39.45K | Feb 24, 2026 | Employee Stock Purchase Plan |
| Abhijit Y. Talwalkar Director | Feb 23, 2026 | 5,312 | $773.98K | Feb 23, 2026 | Stock Option Exercise |
| Chad Patterson Officer | Dec 2, 2025 | 280 | $51.75K | Dec 2, 2025 | Employee Stock Purchase Plan |
| Abhijit Y. Talwalkar Director | Nov 10, 2025 | 5,312 | $924.96K | Nov 10, 2025 | Stock Option Exercise |
| Daniel G. Wilson Officer | Oct 31, 2025 | 8,000 | $1.66M | Oct 31, 2025 | Restricted Stock |
| Daniel G. Wilson Officer | Sep 3, 2025 | 5,000 | $875.00K | Sep 3, 2025 | Restricted Stock |
| Sumi Shrishrimal Officer | Aug 22, 2025 | 653 | $109.13K | Aug 22, 2025 | Restricted Stock |
| Marc Wade Rosenbaum Officer | Aug 11, 2025 | 226 | $35.92K | Aug 11, 2025 | Employee Stock Purchase Plan |
| Abhijit Y. Talwalkar Director | Aug 11, 2025 | 5,312 | $839.38K | Aug 11, 2025 | Stock Option Exercise |
| Chad Patterson Officer | Aug 6, 2025 | 2,555 | $406.17K | Aug 6, 2025 | Restricted Stock |
| Quentin S. Blackford Officer, Director | Aug 5, 2025 | 30,000 | $4.82M | Aug 5, 2025 | Restricted Stock |
| Mark J. Rubash Director | Aug 5, 2025 | 15,000 | $2.41M | Aug 5, 2025 | Stock Option Exercise |
Congress trades
1 trade in iRhythm reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Donna Shalala FL27 | Sold | Jun 24, 2019 | $1K–15K | Apr 27, 2020 308 days late |
See a number that looks wrong?